140 related articles for article (PubMed ID: 2018547)
1. Low glucose-1, 6-bisphosphate and high fructose-2, 6-bisphosphate concentrations in muscles of patients with glycogenosis types VII and V.
Yamada Y; Kono N; Nakajima H; Shimizu T; Kiyokawa H; Kawachi M; Ono A; Nishimura T; Kuwajima M; Tarui S
Biochem Biophys Res Commun; 1991 Apr; 176(1):7-10. PubMed ID: 2018547
[TBL] [Abstract][Full Text] [Related]
2. Glucose 1,6-bisphosphate and fructose 2,6-bisphosphate levels in different types of rat skeletal muscle.
Bassols AM; Cussó R; Carreras J
Comp Biochem Physiol B; 1987; 88(3):843-5. PubMed ID: 2827951
[TBL] [Abstract][Full Text] [Related]
3. Effects of long-term streptozotocin diabetes on cytoskeletal and cytosolic phosphofructokinase and the levels of glucose 1,6-bisphosphate and fructose 2,6-bisphosphate in different rat muscles.
Chen-Zion M; Livnat T; Beitner R
Biochem Med Metab Biol; 1994 Dec; 53(2):137-44. PubMed ID: 7710770
[TBL] [Abstract][Full Text] [Related]
4. Myogenic hyperuricemia. A common pathophysiologic feature of glycogenosis types III, V, and VII.
Mineo I; Kono N; Hara N; Shimizu T; Yamada Y; Kawachi M; Kiyokawa H; Wang YL; Tarui S
N Engl J Med; 1987 Jul; 317(2):75-80. PubMed ID: 3473284
[TBL] [Abstract][Full Text] [Related]
5. The concentrations of glucose 1,6-bisphosphate and other regulatory metabolites, and the activities of enzymes of the glycogen metabolism in the perfused rabbit psoas muscle.
Bauer HP; Birkel G; Hofer HW
Int J Biochem; 1986; 18(1):73-7. PubMed ID: 3002883
[TBL] [Abstract][Full Text] [Related]
6. Excess purine degradation in exercising muscles of patients with glycogen storage disease types V and VII.
Mineo I; Kono N; Shimizu T; Hara N; Yamada Y; Sumi S; Nonaka K; Tarui S
J Clin Invest; 1985 Aug; 76(2):556-60. PubMed ID: 3861621
[TBL] [Abstract][Full Text] [Related]
7. [Glycogenosis (molecular mechanism of muscle glycogenosis)].
Tarui S; Mineo I; Nakajima H; Kono N
Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):637-42. PubMed ID: 3270875
[No Abstract] [Full Text] [Related]
8. Type VII glycogenosis (muscle and erythrocyte phosphofructokinase deficiency).
Tarui S; Kono N; Kuwajima M; Ikura Y
Monogr Hum Genet; 1978; 9():42-7. PubMed ID: 153468
[No Abstract] [Full Text] [Related]
9. Myogenic hyperuricemia: a comparative study between type V and type VII glycogenosis.
Hara N; Mineo I; Kono N; Kiyokawa H; Kawachi M; Yamada Y; Nakajima H; Shimizu T; Kuwajima M; Wang YL
Adv Exp Med Biol; 1989; 253A():381-6. PubMed ID: 2624217
[No Abstract] [Full Text] [Related]
10. [Clinical and biochemical correlations in certain metabolic myopathies].
de Barsy T
Bull Mem Acad R Med Belg; 1992; 147(10):385-92; discussion 392-3. PubMed ID: 1303789
[TBL] [Abstract][Full Text] [Related]
11. Binding of hexose bisphosphates to muscle phosphofructokinase.
Foe LG; Latshaw SP; Kemp RG
Biochemistry; 1983 Sep; 22(19):4601-6. PubMed ID: 6313044
[TBL] [Abstract][Full Text] [Related]
12. Changes in glucose 1,6-bisphosphate content in rat skeletal muscle during contraction.
Bassols AM; Carreras J; Cussó R
Biochem J; 1986 Dec; 240(3):747-51. PubMed ID: 3827864
[TBL] [Abstract][Full Text] [Related]
13. Glucose 1,6-bisphosphate and fructose 2,6-bisphosphate in muscle from healthy humans and chronic alcoholic patients.
Cadefau JA; Andrés V; Carreras J; Vernet M; Grau JM; Urbano-Márquez A; Cussó R
Alcohol Alcohol; 1992 May; 27(3):253-6. PubMed ID: 1449560
[TBL] [Abstract][Full Text] [Related]
14. PHOSPHOFRUCTOKINASE DEFICIENCY IN SKELETAL MUSCLE. A NEW TYPE OF GLYCOGENOSIS.
TARUI S; OKUNO G; IKURA Y; TANAKA T; SUDA M; NISHIKAWA M
Biochem Biophys Res Commun; 1965 May; 19():517-23. PubMed ID: 14339001
[No Abstract] [Full Text] [Related]
15. Endotoxin increases the liver fructose 2,6-bisphosphate concentration in fasted rats.
Miller BC; Ishikawa E; Uyeda K; Cottam GL
Biochem Biophys Res Commun; 1989 Dec; 165(3):1072-8. PubMed ID: 2558647
[TBL] [Abstract][Full Text] [Related]
16. Phosphofructokinase in rat lung during perinatal development: characterization of subunit composition and regulation by fructose 2,6-bisphosphate and glucose 1,6-bisphosphate.
Heesbeen EC; Rijksen G; Batenburg JJ; van Golde LM; Staal GE
Biochim Biophys Acta; 1987 May; 924(2):284-91. PubMed ID: 2952174
[TBL] [Abstract][Full Text] [Related]
17. Altered glucose 1,6-bisphosphate and fructose 2,6-biphosphate levels in low-frequency stimulated rabbit fast-twitch muscle.
Green HJ; Cadefau J; Pette D
FEBS Lett; 1991 Apr; 282(1):107-9. PubMed ID: 2026244
[TBL] [Abstract][Full Text] [Related]
18. Responses of fatigable and fatigue-resistant fibres of rabbit muscle to low-frequency stimulation.
Cadefau JA; Parra J; Cussó R; Heine G; Pette D
Pflugers Arch; 1993 Sep; 424(5-6):529-37. PubMed ID: 8255737
[TBL] [Abstract][Full Text] [Related]
19. Oscillatory synthesis of glucose 1,6-bisphosphate and frequency modulation of glycolytic oscillations in skeletal muscle extracts.
Andrés V; Schultz V; Tornheim K
J Biol Chem; 1990 Dec; 265(35):21441-7. PubMed ID: 2254306
[TBL] [Abstract][Full Text] [Related]
20. Glycogen storage disease in skeletal muscle. Morphological, ultrastructural and biochemical aspects in 10 cases.
Cabello A; Benlloch T; Franch O; Feliú JF; Ricoy JR
Acta Neuropathol Suppl; 1981; 7():297-300. PubMed ID: 6939256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
